Australia, Oct. 28 -- Zenas BioPharma Inc., owns the trademark (2574236) for 'OBCEYO' till Aug. 6, 2035.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system.]
Type of Mark: Word
Date of Acceptance: Aug. 18
Registration Advertised: Oct. 27
For further details contact Duncan Cotterill Lawyers.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2574236.
Disclaimer: Curated by HT Syndication.
